Date:
Time:
To attend this teleconference via web-cast, please go to the Company's website: www.pressurebiosciences.com
To attend this teleconference via telephone: Dial-in: (800) 344-6491 Participant code: 3034253
For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call ends, and will be accessible through the Company's website.
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (PBI) is a publicly-traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences' field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of chemical reactions, immunodiagnostics, and protein purification.
Investor Contacts: Richard T. Schumacher, President & CEO Edward H. Myles, Senior Vice President of Finance & CFO Pressure BioSciences, Inc. (T) 508-230-1828
SOURCE Pressure BioSciences, Inc.